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doi:10.1016/j.kjms.2012.04.010Abstract Lymphoepithelioma-like carcinoma (LELC) is best known to occur in the naso-
pharynx. When LELC occurs in the urinary tract, this extremely rare neoplasm most commonly
affects the bladder but has also been reported in the renal pelvis, ureter, prostate [1], and
urethra [2]. We present a case of LELC arising in the right proximal ureter of a 64-year-old male
patient with hydronephrosis and nausea. Computed tomography demonstrated right ureter
tumor. On biopsy, the patient was diagnosed with infiltrating urothelial carcinoma. An opera-
tion consisting of right nephroureterectomy and bladder cuff removal was carried out. The
pathologic examination showed pure subtype of LELC, pT3N0. Unlike lymphoepithelioma in
the nasopharynx, immunohistochemical analysis of this urinary LELC was negative for the Ep-
steineBarr virus. No disease progression was noted at 6 months’ follow-up. Only eight previous
cases of LELC involving the ureter have been reported, and a review of the available literature
and a summary of ureter cases are presented here. This is the first report of a ureteral LELC
case and third urothelial LELC cases [3] in Taiwan.
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Lymphoepithelioma is an undifferentiated, malignant,
epithelial tumor of the nasopharynx that is histologically
distinct by virtue of a prominent lymphoid infiltrate sugges-
tive of malignant lymphoma [4,5]. Tumors of similar histo-
logic type have been described at sites other than the
nasopharynx, including the lung, stomach, cervix, and skin,
and are known as lymphoepithelioma-like carcinoma (LELC).
Primary urothelial LELC, occurring in the bladder, was first
described in 1991 by Zukerberg et al. [6]. LELC is usually
muscle-invasive at the time of diagnosis (90% are pT2 or
pT3) [7]. When LELCs arise from the urinary tract,
lymphoepithelioma-like carcinoma bladder (LELCB) is most
common. There are around 80 reported cases concerning
bladder LELCs to date. As for upper urinary tract LELCs, there
areonly nine cases [8e15] in theureter and sevencases in the
renal pelvis [2,16e20]. Amin et al. [21] categorized LELCB as
pure (100%), predominant (>50%), and focal (<50%)
according to the proportion of LELC and other neoplasms
such as urothelial carcinoma and squamous cell carcinoma.
Patients with pure and predominant LELCB were reported toFigure 1. (A) Nests or sheets of cancer cells within abundant
epithelium without dysplasia (hematoxylin and eosin stain; origin
exhibiting vesicular nuclei with distinct nucleoli and brisk mitotic
original magnification, 40). (C) Positive cytokeratin immunoreacti
(immunohistochemical stain; original magnification, 20). (D) Po
covering transitional epithelium (immunohistochemical stain; origihave a better prognosis, whereas patients with focal LELCB
were reported to have a poor prognosis similar to conven-
tional bladder carcinoma of the same stage. All nine cases of
ureter LELC (LELCU) are pure form, and no death related to
specific disease has been documented so far.Case report
A 64-year-old man presented with a history of nausea and
vomiting. The patient did not smoke, nor had hebeenexposed
to carcinogenic material during his lifetime. He visited our
emergency department, and right hydronephrosis was iden-
tified on ultrasonography. Urinalysis revealed microscopic
hematuria and urine cytology showed some atypical cells.
Computed tomography revealed right middle third ureteral
malignancy without evidence of lymphadenopathy and
metastasis. Urological consultation was obtained. Uretero-
scopy and biopsy of right ureteral tumorwere performed. The
pathologic examination revealed diffuse infiltration of pleo-
morphic cancer cells within the desmoplastic stroma, and
a pathologic diagnosis of infiltrating urothelial carcinoma,lymphoid stroma focally covered by degenerated transitional
al magnification, 20). (B) Syncytial pattern of cancer cells
activity within lymphoid stroma (hematoxylin and eosin stain;
vity in the cancer cells and the covering transitional epithelium
sitive cytokeratin 7 immunoreactivity in cancer cells and the
nal magnification, 20).
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Lymphoepithelioma-like carcinoma of the ureter 511high grade, wasmade. After a discussion with this patient and
his family, right radical nephroureterectomywithbladder cuff
removal was carried out.
Upon opening of the ureter, a solitary 2.2-cm ulcerated
tumor was identified protruding into the lumen of the
middle ureter, around 14 cm from the distal margin of the
surgical resection. No other lesion was noted on the bladder
cuff, ureter, or renal pelvis. Histologic sections of the
neoplasm showed that the tumor had invaded beyond the
muscularis propria into the periureteric tissue. The tumor
was composed of nests or sheets within abundant lymphoid
stroma focally covered by degenerated transitional
epithelium without dysplasia (Figs. 1A and 1B). Neoplastic
cells showed positive immunohistochemical staining for
cytokeratin 7 (Figs. 1C and 1D); a cytokeratin 20 stain was
positive in the superficial transitional epithelium but
negative in the cancer cells. Latent membrane protein 1
immunostaining and in situ hybridization for EpsteineBarr
virus were (EBV) negative.
The patient did not receive any adjuvant chemotherapy
and radiotherapy postoperatively. He remains well without
evidence of disease at 6 months after the surgery.T
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LELCs can arise in many sites, such as the salivary gland,
thymus, lung, stomach, skin, and urothelium. The first case
of urothelium (bladder) was reported in 1991 by Zukerberg
et al. [6], and LELCs have been classified as a separate
variant of urothelial carcinoma in the World Health Orga-
nization 2004 classification of urothelial tumors [22].
Besides arising in the bladder, LELCs arising from the renal
pelvis [2,16e20], ureter [8e15], prostate [1], and urethra
[2] were also reported. In order to characterize the
malignancy, LELC is subdivided histologically based on the
percentage of non-LELC components. The subtypes were
pure (100%), predominant (more than 50%), and focal (less
than 50%), according to Amin et al.’s suggestion [21].
According to the study of Porcaro et al. [7], LELCB histo-
logical subtypes resulted pure in 40%, predominant in 37%,
and focal in 23%. They also observed that the disease-free
survival and disease-specific survival rate was 81% and
93% in the pure LELCB group (mean follow-up, 48 months),
82% and 93% in the predominant LELCB group (mean follow-
up, 32 months), and 0% and 0% in the focal LELCB group
(mean follow-up, 30 months), respectively [7]. That is to
say, the purer the LELCs cells, the better the prognosis.
The reports on nine patients including the present cases
of primary LELCU from English and Slovenian populations
were collected from 1998 to 2011. The clinical data are
summarized and shown in Table 1 [7e14]. The histopatho-
logic data are shown in Table 2. [7e14].
The average patient age was 68.2 years (58e76), and
five male and four female patients were included. The right
and left ureters were affected with even distribution (5 vs.
4). The percentage of upper, middle, and lower ureter is
the same (33.3%), and hematuria was the most common
symptom described in eight persons (88.8%). Pathological
stage was assessed as pT2 in four cases and pT3 in three
cases; no lymph node metastasis was described in the re-
ported literature. Seven cases were muscle-invasive,
Table 2 Ureter lymphoepithelioma-like carcinoma (LELC) neoplasms pathologic staining summary.
Case report CD20 CD3 CD30 Ck AE1/3 CK7 CK20 EBV Other stains Urine cytology
Chalik [8] (þ) (þ) N/A N/A (þ) (þ) N/A CD68 Atypia
Ng [10] N/A (þ) N/A (þ) N/A N/A (e) AE3(e) N/A
Roig [11] N/A N/A N/A (þ) N/A N/A (e) p53 HER2/neu/c-erb B2 UCHL-1 N/A
Terai [12] (þ) (þ) N/A (þ) (e) (e) (e) Malignant
Oz and Sedmak [14] N/A N/A N/A N/A N/A N/A N/A N/A
Peter Ma [9] (e) N/A N/A (þ) (þ) (e) (e) Negative
Daniela [7] N/A N/A N/A (þ) (þ) (þ) (e) p63þ CK903 N/A
Val-Bernal [13] N/A (þ) (þ) (þ) (þ) N/A N/A CK18,p53 Malignant
Present case N/A N/A N/A N/A (þ) (e) (e) Atypia
Percentage 66.67% 100% 1/1 100% 83.33% 40% 0% Abnormal: 80%
512 S.-C. Wen et al.whereas no description was given in the other two cases. In
all cases, LELCUs were treated with surgery alone without
neoadjuvant or adjuvant chemotherapy and radiotherapy
(including radical nephroureterectomy and bladder cuff
removal in 6, ureterectomy in 2, and partial nephrectomy
combined with ureterectomy in 1). The mean follow-up
period was 18.5 months (range 5e36 months). The outcome
showed that eight patients (88.89%) lived with no evidence
of the disease, and one patient (11.11%) died for causes
unrelated to the primary disease (pancreatic cancer 3 years
postoperatively). The survival rate related to ureteral LELC
was 100% (compared to 93% both in pure and predominant
LELCB and 0% in focal LELCB [7]).
Positive antibody reaction against cytokeratin 7 and
cytokeratin AE1/3 was noted in the literature with rates of
100% (6 out of 6) and 83.33% (5 out of 6), respectively. Such
findings may suggest the epithelial component of these
neoplasms. Nasopharyngeal lymphoepithelioma has a close
pathogenic relationship with EBV, and there is a strong
association between p53 overexpression and EBV-encoded
RNA status in the nasopharynx [23]. Besides arising from the
nasopharynx, lymphoepithelioma from the lung, stomach,
thymus, and salivary gland also showed the existence of
EBV [23e30]. However, urothelial LELC (includes current
case) occurring in the renal pelvis, bladder, prostate, and
urethra failed to demonstrate the presence of EBV. These
data suggested that EBV is not necessary for the develop-
ment of LELC, and abnormalities of p53 regulation are
crucial in the development of urothelial LELC [31e34].
Like nasopharyngeal lymphoepithelioma, LELCB was re-
ported to be sensitive to both cisplatin-based chemo-
therapy and radiotherapy. Chemotherapy includes three to
five courses of methotrexate, vinblastine, doxorubicin, and
cisplatin, as reported in the literature [21,27,35e37].
Chemotherapy and radiotherapy were not administered
alone, but were used as adjuvant therapy for treating
“focal” subtype LELCB. In the case of “pure” and
“predominant” subtypes, Porcaro et al. [7] reported that
there was no clear benefit for adjuvant therapy. For the
same reason, all LELCUs reported in the literature were of
“pure” subtypes, and all these cases did not recur after
surgical treatment alone. The reason why LELCs of “pure”
or “predominant” subtypes have better prognosis than
those of “focal subtypes” has not been well understood so
far. Zukerberg et al. [6] considered that the purer compo-
nent of LELC may incite stronger immune reaction by thehost, such as hematuria and pyuria. On the contrary, we
believe that the stronger immunity status of the host may
incite fewer (and purer) varieties of components of LELC,
and a stronger immune status of the host has a better
prognosis than a more vulnerable immune status.
Malignant urine cytology is usually associated with
conventional urothelial carcinoma. Discussions on the
cytology of lymphoepithelioma are rare, and there are only
few reports about the cytological presentation of these
tumors in the nasopharynx, lungs, and salivary glands.
Atypical and malignant cells in urine cytological examina-
tion were reported in the two cases of LELCB [38,39] and
four cases of LELCU (including the current case) [9,13,14].
Cai and Parwani [40] reported that cytomorphologic
features included large tumor cells with high nuclear to
cytoplasmic ratios, vesicular chromatin, and prominent
nucleoli, presenting as single cells or intermixed with
inflammatory cells [40]. However, a diagnosis made on the
basis of a urine specimen is very difficult because of the
rarity of the tumor. Urine cytology is very simple and
noninvasive. Neoplasms of conventional urothelial carci-
noma and LELC could be diagnosed or monitored by urine
cytology, especially for high-grade neoplasms.
To sum up, LELCUs are extremely rare neoplasms
and are almost muscle-invasive at diagnosis. LELCUs
usually present as hematuria, and a definite diagnosis is
very challenging to make before many specimens
are obtained. However, LELCUs have been successfully
treated with surgery alone (without adjuvant therapy),
and the disease-specific survival rate is excellent
in the limited number of published reports. To date,
we report the ninth documented case of LELCUs.
We believe that more cases of urothelial LELC
are needed to fully understand the nature of this rare
entity. This is the first report of a ureteral LELC case and
third urothelial LELC cases3 in Taiwan population.
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